Date

Monday, 30 May 2022

Location

Online
European Medicines Agency, Amsterdam, the Netherlands

Event summary

The meeting was held in the context of EMA’s continuous endeavours to foster regular interactions with industry stakeholders on topics of common interest, and in this instance, big data.

Objectives of this meeting were to:

  • Gather industry’s views on big data priorities and needs for the coming years in order to re-enforce existing Big Data recommendations actions and identify gaps for new ones.
  • Consider and feed industry suggestions received during the meeting into the Big Data Steering Group workplan’s 2025 finalisation.

Documents

Share this page